VKORC1多态性和对维生素K对抗剂的完全耐药性:大约有两个病例
Ilham Benyamna1,2, Houda El Fissi2, Fadoua Bouzid2,3
1Department of Cardiology and Internal Medicine, Inezgane Provincial Hospital, Agadir, Morocco.
对维生素K对抗剂的完全耐药性是一种罕见的疾病,可能与特定的VKORC1基因突变有关. 识别这些遗传因素对于影响患者的有效治疗管理至关重要.
科学领域:
- 遗传学 遗传学是一种遗传学.
- 药理学 药理学是指药理学的学科.
- 血液学 血液学 血液学
背景情况:
- 维生素K对抗剂 (VKAs) 是重要的抗凝剂.
- 对VKA的完全耐药性很少见,但会带来重大的治疗挑战.
- 直接口服抗凝剂可能并不总是合适的替代品.
更多相关视频
11:33Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
Published on: March 12, 2013
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Single Nucleotide Polymorphisms-SNPs
Determination of Michaelis Constant and Maximum Elimination Rate
These parameters can be estimated by analyzing plasma concentration data post-drug administration. A notable example of this application is phenytoin, a drug with capacity-limited kinetics. It's recommended that phenytoin should be administered at two...
Treatment Resistant Cancers
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
